Drug Database
Back to search

Poland· PL-100206550

Cyanokit

A hydroxocobalamin product containing hydroxocobalaminum, registered in Poland by SERB S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC V03AB33

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCyanokitATCV03AB33REGISTER NO.PL-100206550PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydroxocobalaminumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydroxocobalamin is registered in 11 of 19 countries.

Countries holding a registration under ATC V03AB33 (hydroxocobalamin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search hydroxocobalamin products by name

Hydroxocobalamin · ATC V03AB33

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Hydroxocobalaminum
Manufacturer
SERB S.A.
Country
Poland (PL)
ATC code
V03AB33
ATC class
Hydroxocobalamin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990688258
  • gtin
    05909990689934
  • gtin
    05055956400225
  • gtin
    05055956400621

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for hydroxocobalamin.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydroxocobalamin against other medicinesHow interaction checks work

Hydroxocobalamin · interactions on record

40 records

  • 2 moderate
  • 38 info

Most severe, free to view

  • ChloramphenicolJ01BA01moderate
  • Arsenic trioxideL01XX27moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hydroxocobalamin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hydroxocobalamin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Erycytol Depot
  • Belgium · Hydroxocobalamine Acetate Sterop
  • Cyprus · Articlox
  • Germany · Depogamma, Lophakomp-B 12-Depot
  • Denmark · Cohemin, Hydroxocobalamin Alternova
  • Spain · Hidroxocobalamina Basi, Megamilbedoce
  • Finland · Cohemin, Hydroxocobalamin G.L. Pharma
  • France · Dodecavit, Novobedouze
  • United Kingdom (Northern Ireland) · Cobalin-H, Hydroxocobalamin Accord Healthcare
  • Greece · Articlox
  • Ireland · Hydroxocobalamin G.L. Pharma, Hydroxy-Vit
  • Iceland · Cyanokit, Hydroxocobalamin G.L. Pharma
  • Italy · Neo Cytamen
  • Liechtenstein · Cyanokit
  • Malta · Articlox
  • Netherlands · Hydrocobamine, Hydroxocobalamine Focus Care
  • Norway · Cyanokit, Hydroxocobalamin Basi
  • Portugal · Hidroxocobalamina Basi
  • Sweden · Hydroxocobalamin Alternova, Hydroxocobalamin G.L. Pharma
  • Slovenia · Hidroksokobalamin Orion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/93df6402-320c-4851-b44e-ae576ee3b9f1
GET /v1/drugs/93df6402-320c-4851-b44e-ae576ee3b9f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania roztworu do infuzji",
  "source": "urpl",
  "strength": "2,5 g",
  "packaging": "05909990688258 ¦ Rp ¦ Skasowane ¦ EU/1/07/420/001 ¦ 49029\n1 zestaw 2 fiolki + 1 zestaw do infuzji + 2 urządzenia` transferowe + 1 krótki cewnik\n05909990689934 ¦ Rp ¦ Skasowane ¦ 49201\n1 fiol. 2,5 g\n05055956400225 ¦ Rp ¦ Skasowane ¦ EU/1/07/420/001 ¦ 135644\n1 zestaw 2 fiolki + 1 zestaw do infuzji + 2 urządzenia` transferowe + 1 krótki cewnik\n05055956400621 ¦ Rp ¦ EU/1/07/420/001 ¦ 136868\n2 fiol.  ¦ 1 zestaw  do infuzji ¦ 2 urządzenie  transferowe + 1 krótki cewnik",
  "substance": "Hydroxocobalamin 2.5 g",
  "common_name": "Hydroxocobalaminum",
  "pl_product_id": "100206550",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about hydroxocobalamin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console